R Dummer
The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients
Yoo J, Busschots A, Hauben E, Bervoets A, Woei-A-Jin F, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Ranki A, Vakeva L, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen M, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Arumainathan A, Azurdia R, Klemke C, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Bur C, Folkes A, Benstead K, Twigger R, Rieger K, Brown R, Sanches J, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco F, Querfeld C, Willemze R, Latzka J, Scarisbrick J, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Child F, Guenova E, Quaglino P, Prince H, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Koletsa T, Jonak C, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Pham-Ledard A, Beylot-Barry M, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio A, Dummer R, Pimpinelli N, Grandi V, Trautinger F. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol 2018; 181:350-357.
Nov 25, 2018The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients
Nov 25, 2018Br J Dermatol 2018; 181:350-357
Yoo J, Busschots A-M, Hauben E, Bervoets A, Woei-A-Jin F J S H, Matin R, Collins G, Weatherhead S, Frew J, Bayne M, Dunnill G, McKay P, Ranki A, Vakeva L, Vydianath B, Amel-Kashipaz R, Marinos L, Oikonomidi A, Stratigos A, Vignon-Pennamen M-D, Climent F, Gonzalez-Barca E, Georgiou E, Senetta R, Zinzani P, Arumainathan A, Azurdia R, Klemke C-D, Enz P, Pujol R, Quint K, Geskin L, Hong E, Evison F, Vermeer M, Cerroni L, Kempf W, Kim Y, Bur C, Folkes A, Benstead K, Twigger R, Rieger K, Brown R, Sanches J A, Miyashiro D, Akilov O, McCann S, Sahi H, Damasco F M, Querfeld C, Willemze R, Latzka J, Scarisbrick J J, Whittaker S, Nikolaou V, Tomasini C, Amitay I, Prag Naveh H, Ram-Wolff C, Battistella M, Alberti-Violetti S, Stranzenbach R, Gargallo V, Muniesa C, Child F, Guenova E, Quaglino P, Prince H M, Papadavid E, Hodak E, Bagot M, Servitje O, Berti E, Ortiz-Romero P, Stadler R, Patsatsi A, Knobler R, Koletsa T, Jonak C, Wobser M, Geissinger E, Wehkamp U, Weichenthal M, Cowan R, Parry E, Harris J, Wachsmuth R, Turner D, Bates A, Healy E, Pham-Ledard A, Beylot-Barry M, Porkert S, Mitteldorf C, Estrach T, Combalia A, Marschalko M, Csomor J, Szepesi A, Cozzio Antonio, Dummer R, Pimpinelli N, Grandi V, Trautinger F
Individualized Treatment Approaches for Langerhans Cell Histiocytosis
Roider E, Dummer R, French L, Cozzio A, Hoetzenecker W, Jochum W, Balabanov S, Kerl K, Kamarachev J, Schaller M, Metzler G, Fehrenbacher B, Signer C, Guenova E. Individualized Treatment Approaches for Langerhans Cell Histiocytosis. Br J Dermatol 2017
Nov 30, 2017Individualized Treatment Approaches for Langerhans Cell Histiocytosis
Nov 30, 2017Br J Dermatol 2017
Roider E, Dummer R, French L E, Cozzio Antonio, Hoetzenecker W, Jochum W, Balabanov S, Kerl K, Kamarachev J, Schaller M, Metzler G, Fehrenbacher B, Signer C, Guenova E
An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel
Thurneysen S, Levesque M, Mangana J, Goldinger S, Guenova E, Ziegler M, Nägeli M, Jaberg-Bentele N, Kunz M, Nagel H, Cheng P, Dummer R. An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel. Br J Dermatol 2016
May 11, 2016An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel
May 11, 2016Br J Dermatol 2016
Thurneysen S, Levesque M P, Mangana J, Goldinger S M, Guenova Emmanuella, Ziegler M, Nägeli M, Jaberg-Bentele N, Kunz M, Nagel H W, Cheng P F, Dummer R
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
Kunz M, French L, Kamarachev J, Guenova E, Cozzio A, Dippel M, Jenni D, Mangana J, Belloni B, Dreier J, Frauchiger A, Goldinger S, Urosevic-Maiwald M, Dummer R. Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study. J Eur Acad Dermatol Venereol 2015; 30:293-8.
Oct 27, 2015Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
Oct 27, 2015J Eur Acad Dermatol Venereol 2015; 30:293-8
Kunz M, French L E, Kamarachev J, Guenova Emmanuella, Cozzio A, Dippel M, Jenni D, Mangana J, Belloni B, Dreier J, Frauchiger A L, Goldinger S M, Urosevic-Maiwald M, Dummer R
Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma
Guenova E, Fierlbeck G, Kamarashev J, Kerl K, French L, Dummer R, Berneburg M, Urosevic-Maiwald M, Voykov B, Mehra T, DeSimone J, Hoetzenecker W, Schanz S, Cozzio A. Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma. Br J Dermatol 2014; 171:891-4.
Sep 2, 2014Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma
Sep 2, 2014Br J Dermatol 2014; 171:891-4
Guenova Emmanuella, Fierlbeck G, Kamarashev J, Kerl K, French L E, Dummer R, Berneburg M, Urosevic-Maiwald M, Voykov B, Mehra T, DeSimone J A, Hoetzenecker W, Schanz S, Cozzio A
Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre
Jenni D, Karpova M, Seifert B, Golling P, Cozzio A, Kempf W, French L, Dummer R. Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre. Br J Dermatol 2011; 164:1071-7.
May 1, 2011Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre
May 1, 2011Br J Dermatol 2011; 164:1071-7
Jenni D, Karpova M B, Seifert B, Golling Ph, Cozzio Antonio, Kempf W, French L E, Dummer R
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol 2011; 23:531-6.
Apr 28, 2011First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
Apr 28, 2011Ann Oncol 2011; 23:531-6
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P H, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S M, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK)
Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile
Donghi D, Kerl K, Dummer R, Schoenewolf N, Cozzio A. Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile. J Eur Acad Dermatol Venereol 2010; 24:1230-4.
Oct 1, 2010Cutaneous angiosarcoma: own experience over 13 years. Clinical features, disease course and immunohistochemical profile
Oct 1, 2010J Eur Acad Dermatol Venereol 2010; 24:1230-4
Donghi D, Kerl K, Dummer R, Schoenewolf N, Cozzio Antonio
Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib
Donghi D, Dummer R, Cozzio A. Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib. Br J Dermatol 2009; 162:697-9.
Dec 21, 2009Complete remission in a patient with multifocal metastatic cutaneous angiosarcoma with a combination of paclitaxel and sorafenib
Dec 21, 2009Br J Dermatol 2009; 162:697-9
Donghi D, Dummer R, Cozzio Antonio
Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides
Michaelis S, Cozzio A, Kempf W, Graf P, Burg G, Dummer R. Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides. Dermatology (Basel) 2004; 209:72-4.
Jan 1, 2004Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides
Jan 1, 2004Dermatology (Basel) 2004; 209:72-4
Michaelis S, Cozzio Antonio, Kempf W, Graf P, Burg G, Dummer R
Prevention campaign against skin cancer
Heinzerling L, Dummer R, Panizzon R, Bloch P, Barbezat R, Burg G, Task force 'swiss cancer' of the swiss cancer league. Prevention campaign against skin cancer. Dermatology (Basel, Switzerland) 2002; 205:229-33.
Jan 1, 2002Prevention campaign against skin cancer
Jan 1, 2002Dermatology (Basel, Switzerland) 2002; 205:229-33
Heinzerling Lucie, Dummer R, Panizzon R G, Bloch P H, Barbezat R, Burg G, Task force 'swiss cancer' of the swiss cancer league
Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses
Heinzerling L, Feige K, Rieder S, Akens M, Dummer R, Stranzinger G, Moelling K. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. Journal of molecular medicine (Berlin, Germany) 2001; 78:692-702.
Jan 1, 2001Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses
Jan 1, 2001Journal of molecular medicine (Berlin, Germany) 2001; 78:692-702
Heinzerling Lucie, Feige K, Rieder S, Akens M K, Dummer R, Stranzinger G, Moelling K
Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
Heinzerling L, Urbanek M, Funk J, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer 2000; 89:1835-44.
Oct 15, 2000Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma
Oct 15, 2000Cancer 2000; 89:1835-44
Heinzerling Lucie, Urbanek M, Funk J O, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R
[Immuno-intervention in cutaneous lymphomas]
Dummer R, Heinzerling L, Schmid M, Burg G. [Immuno-intervention in cutaneous lymphomas]. Praxis 2000; 89:1471-6.
Sep 14, 2000[Immuno-intervention in cutaneous lymphomas]
Sep 14, 2000Praxis 2000; 89:1471-6
Dummer R, Heinzerling Lucie, Schmid M H, Burg G
Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
Heinzerling L, Dummer R, Kempf W, Schmid M, Burg G. Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Archives of dermatology 2000; 136:374-8.
Mar 1, 2000Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
Mar 1, 2000Archives of dermatology 2000; 136:374-8
Heinzerling Lucie, Dummer R, Kempf W, Schmid M H, Burg G
Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient
Heinzerling L, Dummer R, Wildberger H, Burg G. Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology (Basel, Switzerland) 2000; 201:154-7.
Jan 1, 2000Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient
Jan 1, 2000Dermatology (Basel, Switzerland) 2000; 201:154-7
Heinzerling Lucie, Dummer R, Wildberger H, Burg G
Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis?
Anliker M, Dummer R, Burg G. Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis?. Dermatology (Basel) 1997; 195:176-8.
Jan 1, 1997Unilateral agminated angiofibromas: a segmental expression of tuberous sclerosis?
Jan 1, 1997Dermatology (Basel) 1997; 195:176-8
Anliker Mark, Dummer R, Burg G